These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8107309)

  • 41. Adverse cardiovascular effects of partial correction of renal anemia by recombinant human erythropoietin.
    Frei U; Nonnast-Daniel B; Schäffer J; Koch KM
    Contrib Nephrol; 1990; 82():72-8. PubMed ID: 2093530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morning blood pressure at home predicts erythropoietin-induced hypertension in patients with chronic renal diseases.
    Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Hosoya T
    Clin Exp Nephrol; 2007 Mar; 11(1):66-70. PubMed ID: 17385001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
    Németh I; Túri S; Haszon I; Bereczki C
    Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease.
    Linde T; Wikström B; Andersson LG; Danielson BG
    Scand J Urol Nephrol; 1996 Apr; 30(2):115-20. PubMed ID: 8738056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Risks of Cardiac Disease in Dialysis Patients Study Group.
    Matsumura M; Nomura H; Koni I; Mabuchi H
    Nephron; 1997; 77(2):164-8. PubMed ID: 9346382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension as a possible complication of recombinant human erythropoietin therapy.
    Brunkhorst R; Nonnast-Daniel B; Koch KM; Frei U
    Contrib Nephrol; 1991; 88():118-25; discussion 126. PubMed ID: 2040173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention.
    Beccari M
    Int J Artif Organs; 1994 Jan; 17(1):5-13. PubMed ID: 8188400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
    Berglund B; Ekblom B
    J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of treatment with recombinant human erythropoietin in clinical use: a review of controlled studies.
    Sowade B; Sowade O; Möcks J; Franke W; Warnke H
    Int J Mol Med; 1998 Feb; 1(2):303-14. PubMed ID: 9852232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant erythropoietin and blood pressure.
    Jacquot C; Ferragu-Haguet M; Lefebvre A; Berthelot JM; Peterlongo F; Castaigne JP
    Lancet; 1987 Nov; 2(8567):1083. PubMed ID: 2889986
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of low-dose recombinant human erythropoietin treatment on cognitive performance.
    Viuff SL; Plenge U; Belhage B; Boushel R; Koester T
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Indications of Recombinant Human Erythropoietin in a Single Center: A 10-Year Retrospective Study.
    Guan XZ; Wang LL; Pan X; Liu L; Sun XL; Zhang XJ; Wang DQ; Yu Y
    Front Pharmacol; 2020; 11():1110. PubMed ID: 32848738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure and erythropoietin.
    Lancet; 1988 Feb; 1(8581):351-2. PubMed ID: 2893152
    [No Abstract]   [Full Text] [Related]  

  • 54. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
    Stutz B; Rhyner K; Vögtli J; Binswanger U
    Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of erythropoietin on blood pressure.
    Raine AE; Roger SD
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):76-83. PubMed ID: 1928084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pressor effect of recombinant human erythropoietin: results of home blood pressure measurements in hemodialysis patients.
    Imai Y; Fujikura Y; Minami N; Munakata M; Hashimoto J; Sakuma H; Watanabe N; Nishiyama A; Misawa S; Sekino H
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):51-6. PubMed ID: 8107309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pressor effect of recombinant human erythropoietin: results of ambulatory blood pressure monitoring and home blood pressure measurements.
    Imai Y; Sekino H; Fujikura Y; Munakata M; Minami N; Hashimoto J; Sakuma H; Watanabe N; Misawa S; Nishiyama A
    Clin Exp Hypertens; 1995 Apr; 17(3):485-506. PubMed ID: 7613524
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.